SELLAS Life Sciences Grou... (SLS)

AI Score

Unlock

1.10

0.01 (0.92%)

At close: Apr 03, 2025, 3:59 PM

1.12

1.35%

After-hours: Apr 03, 2025, 06:13 PM EDT

SELLAS Life Sciences Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Revenue	n/a	n/a	1M	7.6M	1.9M	n/a	n/a	n/a	n/a	n/a	9.32M	2.49M	2.04M	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	100K	200K	n/a	n/a	n/a	n/a	3K	355K	1.4M	520K	n/a	20.79M	n/a	n/a	n/a	11.41M	n/a
Gross Profit	n/a	n/a	900K	7.4M	1.9M	n/a	n/a	n/a	-3K	-355K	7.92M	1.97M	2.04M	-20.79M	n/a	n/a	n/a	-11.41M	n/a
Operating Income	-31.51M	-37.87M	-41.95M	-25.29M	-16.98M	-20.04M	-31.09M	-23.04M	-31.87M	-34.22M	-52.22M	-33.84M	-21.2M	-20.79M	-16.63M	-17.52M	-14.55M	-11.41M	-2.4M
Interest Income	632K	525K	317K	6K	26K	118K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	180K	448K	n/a
Pretax Income	-30.88M	-37.34M	-41.3M	-20.94M	-16.77M	-19.37M	-29.05M	-23.5M	-10.86M	-38.59M	-36.61M	-75.63M	-34.38M	-11.48M	-11.99M	-18.39M	-14.37M	-10.96M	-2.4M
Net Income	-30.88M	-37.34M	-40.65M	-20.7M	-16.76M	-19.29M	-27.67M	-23.75M	-23.55M	-63.9M	-36.61M	-76.68M	-34.97M	-11.48M	-11.99M	-18.39M	-14.37M	-10.99M	-2.4M
Selling & General & Admin	12.42M	13.86M	12.58M	11.32M	9.6M	9.92M	12.77M	15.09M	12.01M	10.61M	31.34M	14.6M	6.58M	9.25M	8.75M	8.63M	7.5M	4.67M	633K
Research & Development	19.1M	24.01M	30.27M	21.37M	9.28M	7.29M	18.32M	6.07M	19.86M	23.61M	28.35M	21.08M	14.61M	11.54M	7.87M	8.89M	7.05M	6.75M	1.3M
Other Expenses	n/a	n/a	10M	5.7M	n/a	n/a	-3.03M	n/a	n/a	509K	170K	37K	-13.18M	9.25M	n/a	n/a	7.5M	n/a	n/a
Operating Expenses	31.51M	37.87M	42.85M	32.69M	18.88M	17.21M	31.09M	21.16M	31.87M	34.22M	60.14M	35.81M	21.2M	20.79M	16.63M	17.52M	14.55M	11.41M	2.4M
Interest Expense	n/a	n/a	n/a	n/a	n/a	118K	266K	462K	3.51M	760K	1.11M	807K	33K	n/a	5K	-5K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.39M	n/a	n/a	2.63M	931K	n/a
Cost & Expenses	n/a	37.87M	42.95M	32.89M	18.88M	17.21M	31.09M	21.16M	31.87M	34.22M	61.54M	36.33M	21.2M	20.79M	16.63M	17.52M	14.55M	11.41M	2.4M
Income Tax Expense	n/a	n/a	-649K	-237K	-17K	-81K	-1.38M	253K	243K	365K	-15.45M	1.05M	-1.05M	-9.3M	-4.63M	867K	n/a	25K	n/a
Shares Outstanding (Basic)	612.02M	249.99M	174.56M	139.33M	71.79M	23.03M	2.35M	421.26K	59.75K	46.57K	35.81K	27.05K	18.74K	10.9K	5.51K	4.86K	4.12K	3.8K	3.78K
Shares Outstanding (Diluted)	612.02M	249.99M	174.56M	139.33M	71.79M	23.03M	2.35M	421.26K	59.75K	46.58K	35.81K	27.05K	18.74K	10.9K	5.51K	4.86K	4.12K	3.8K	3.78K
EPS (Basic)	-0.05	-0.15	-0.23	-0.15	-0.23	-0.84	-11.76	-56.39	-394.12	-1.37K	-1.02K	-2.83K	-1.87K	-1.05K	-2.18K	-3.78K	-3.49K	-2.89K	-636.24
EPS (Diluted)	-0.05	-0.15	-0.23	-0.15	-0.23	-0.84	-11.76	-56.39	-394.12	-1.37K	-1.02K	-2.83K	-1.87K	-1.05K	-2.18K	-3.78K	-3.49K	-2.89K	-636.24
EBITDA	-31.51M	529K	-31.95M	-19.66M	-16.4M	668K	n/a	-23.04M	-15.98M	-37.48M	-36.61M	7.63M	-34.38M	-11.32M	-11.82M	-18.22M	-14.24M	-10.93M	-2.4M
EBIT	n/a	-37.34M	-41.3M	-19.59M	-16.98M	-19.37M	-28.78M	-23.04M	-16.51M	-37.83M	-35.5M	-74.82M	-34.34M	-11.48M	-11.99M	-18.38M	-14.37M	-10.96M	n/a
Depreciation & Amortization	n/a	37.87M	457K	1.27M	377K	17.21M	22.04M	3K	3K	355K	440K	452K	49K	163K	172K	162K	131K	36K	n/a